We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
SINGLE-AGENT L-ASPARAGENASE FOR THE TREATMENT OF VINCRISTINE AND DOXORUBICIN-RESISTANT CANINE TRANSMISSIBLE VENEREAL TUMOUR.
- Authors
Macotpet, Arayaporn; Pattarapanwichien, Ekkachai; Suksawat, Fanan
- Abstract
A six-year-old, spayed female, mixed breed, 18.2 kg dog was referred from a private clinic with transmissible venereal tumour (TVT) at the genitalia, which was resistant to vincristine. The treatment plan initially was to use doxorubicin chemotherapy once every three weeks. However, after having given it twice the dog did not respond to the treatment and L-asparagenase, once every two weeks, for four treatments was given as an alternative, leading to a successful treatment with no adverse effects.
- Subjects
VINCRISTINE; CANCER; GENITALIA; THERAPEUTICS; DOGS
- Publication
Veterinary Practitioner, 2019, Vol 20, Issue 1, p56
- ISSN
0972-4036
- Publication type
Article